汗腺螺旋腺瘤临床病理分析  

Clinicopathological Analysis of Spiradenoma

作　　者：娄欣[1] 张全武[1] 肖艳景[1] 赵红梅[1] 和莹莹[1] 

机构地区：[1]郑州市中心医院病理科,河南郑州450007

出　　处：《肿瘤基础与临床》2013年第1期46-47,共2页journal of basic and clinical oncology

摘　　要：目的探讨汗腺螺旋腺瘤的临床病理学特征。方法对2例汗腺螺旋腺瘤患者的临床资料、组织病理学检查结果进行分析,观察其中1例的免疫表型,并复习相关文献。结果汗腺螺旋腺瘤常见于11～40岁,多伴疼痛感,镜下见境界清楚的小叶由2种上皮细胞组成,免疫组化:AE1/AE3(+),P63、CEA部分细胞(+)。结论汗腺螺旋腺瘤是一种少见的良性肿瘤,诊断主要依据临床表现及组织病理学特征,必要时结合免疫组化多可明确诊断。Objective To explore the clinicopathological features of spiradenoma. Methods The clinical data, histopathological examinations of 2 cases and the immunohistochemical examination of 1 case were observed. Mean- while,the relevant literatures were reviewed. Results Spiradenoma was common in the 11-40 years old patients. The patients were usually accompanied with pain. Under microscope, clear-cut lobule was consisted of two kinds of epithelial cells. Immunohistochemical features： AE1/AE3 （ ＋ ） ; some ceils P63, CEA（ ＋ ）. Conclusion Spiradenoma is a kind of rare benign tumor. The diagnosis mostly depends on the clinic symptoms and histological features; in order to confirm this diagnosis, the immunohistochemistry can be used when it is necessary.

关 键 词：汗腺 螺旋腺瘤 免疫组化 

分 类 号：R739.5[医药卫生—肿瘤] R730.56[医药卫生—临床医学]